Abstract
Because of its ease of injection, safety profile, and high patient acceptance, Hylaform may become a leader in the soft-tissue augmentation market in the United States, as it already is worldwide.
| Original language | English |
|---|---|
| Pages (from-to) | 121-126 |
| Number of pages | 6 |
| Journal | Clinics in Plastic Surgery |
| Volume | 28 |
| Issue number | 1 |
| State | Published - 2001 |
| Externally published | Yes |